Effects of lead on the adult brain: A 15-year exploration

American Journal of Industrial Medicine

Volumn 50, Issue 10, 2007, Pages 729-739

  Stewart, Walter F ^a,b,c   Schwartz, Brian S ^b  

^a GEISINGER MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c GEISINGER HEALTH SYSTEM   (United States)

Author keywords

Adult; Environmental; Gray matter; Lead; Longitudinal; MRI; Neuropsychology; Occupational; White matter

Indexed keywords

ORGANOLEAD COMPOUND; TETRAETHYLLEAD;

BRAIN; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GRAY MATTER; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL HEALTH; PATELLA; TIBIA; UNITED STATES; WHITE MATTER; X RAY FLUORESCENCE;

ADULT; AGED; AGING; BALTIMORE; COGNITION; COGNITION DISORDERS; DEMENTIA; DIFFUSION MAGNETIC RESONANCE IMAGING; ENVIRONMENTAL EXPOSURE; HUMANS; KOREA; LEAD; LEAD POISONING, NERVOUS SYSTEM, ADULT; LONGITUDINAL STUDIES; MEMORY DISORDERS; MIDDLE AGED; NEW JERSEY; OCCUPATIONAL EXPOSURE; TETRAETHYL LEAD; TIBIA;

EID: 36849086904     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.20434     Document Type: Conference Paper

References (46)

1. Annest JL, Pirkle JL, Makuc D, Neese JW, Bayse DD, Kovar MG. 1983. Chronological trend in blood lead levels between 1976 and 1980. N Engl J Med 308(23):1373-1377.
2. Armstrong R, Chettle DR, Scott MC, Somervaille LJ, Pendlington M. 1992. Repeated measurements of tibia lead concentrations by in vivo X ray fluorescence in occupational exposure. Br J Ind Med 49(1):14-16.
3. Atamna H, Killilea DW, Killilea AN, Ames BN. 2002. Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. Proc Natl Acad Sci USA 99(23):14807-14812.
4. Balbus-Kornfeld JM, Stewart W, Bolla KI, Schwartz BS. 1995. Cumulative exposure to inorganic lead and neurobehavioural test performance in adults: An epidemiological review. Occup Environ Med 52(1):2-12.
5. Bartzokis G. 2004. Age-related myelin breakdown: A developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25(1):5-18 author reply 49-62.
6. Beattie AD, Moore MR, Goldberg A. 1972. Tetraethyl-lead poisoning. Lancet 2(7766):12-15.
7. Benes FM, Turtle M, Khan Y, Farol P. 1994. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood adolescence, and adulthood. Arch Gen Psychiatry 51(6):477-484.
8. Bleecker ML, Ford DP, Lindgren KN, V H, Walsh KS, Vaughan CG. 2005. Differential effects of lead exposure on components of verbal memory. Occup Environ Med 62(3):181-187.
9. Braak H, Del Tredici K. 2004. Poor and protracted myelination as a contributory factor to neurodegenerative disorders. [comment]. Neurobiol Aging 25(1):19-23.
10. Brody DJ, Pirkle JL, Kramer RA, Flegal KM, Matte TD, Gunter EW, Paschal DC. 1994. Blood lead levels in the US population. Phase 1 of the third national health and nutrition examination survey (NHANES III, 1988 to 1991)[erratum appears in JAMA 1995 Jul 12;274(2):130]. JAMA 272(4):277-283.
11. Cake KM, Bowins RJ, Vaillancourt C, Gordon CL, McNutt RH, Laporte R, Webber CE, Chettle DR. 1996. Partition of circulating lead between serum and red cells is different for internal and external sources of lead. Am J Ind Med 29(5):440-445.
12. Davey FD, Breen KC. 1998a. The interaction between chronic low-level lead and the amyloid beta precursor protein. Amyloid 5(2):90-98.
13. Davey FD, Breen KC. 1998b. Stimulation of sialyltransferase by subchronic low-level lead exposure in the developing nervous system. A potential mechanism of teratogen action. Toxicol Appl Pharmacol 151(1):16-21.
14. Fox DA, Campbell ML, Blocker YS. 1997. Functional alterations and apoptotic cell death in the retina following developmental or adult lead exposure. Neurotoxicology 18(3):645-664.
15. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A. 1991. The cardiovascular health study: Design and rationale. Ann Epidemiol 1(3): 263-276.
16. Glass TA, Rasmussen MR, Schwartz BS. 2006. Neighborhood and obesity in older adults: The Baltimore Memory study. Am J Prev Med 31:455-463.
17. Kempermann G, Gage FH. 2000. Neurogenesis in the adult hippocampus. Novartis found Symp 231:220-235.
18. Kempermann G, Wiskott L, Gage FH. 2004. Functional significance of adult neurogenesis. Curr Opin Neurobiol 14(2):186-191.
19. Links JM, Schwartz BS, Simon D, Bandeen-Roche K, Stewart WF. 2001. Characterization of toxicokinetics and toxicodynamics with linear systems theory: Application to lead-associated cognitive decline. Environ Health Perspect 109(4):361-368.
20. Norris C, Gettler AO. 1925. Poisoning by tetra-ethyl lead: Postmortem and clinical findings. JAMA 85:818-820.
21. Pirkle JL, Brody DJ, Gunter EW, Kramer RA, Paschal DC, Flegal KM, Matte TD. 1994. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA 272(4):284-291.
22. Pirkle JL, Kaufmann RB, Brody DJ, Hickman T, Gunter EW, Paschal DC. 1998. Exposure of the U.S. population to lead, 1991-1994. Environ Health Perspect 106(11):745-750.
23. Regan CM, Fox GB. 1995. Polysialylation as a regulator of neural plasticity in rodent learning and aging. Neurochem Res 20(5):593-598.
24. Roels H, Konings J, Green S, Bradley D, Chettle D, Lauwerys R. 1995. Time-integrated blood lead concentration is a valid surrogate for estimating the cumulative lead dose assessed by tibial lead measurement. Environ Res 69(2):75-82.
25. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC. 2003. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 60(7):989-994.
26. Schafer JH, Glass TA, Bolla KI, Mintz M, Jedlicka AE, Schwartz BS. 2005. Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc 53(3):381-388.
27. Schwartz BS, Bolla KI, Stewart W, Ford DP, Agnew J, Frumkin H. 1993. Decrements in neurobehavioral performance associated with mixed exposure to organic and inorganic lead. Am J Epidemiol 137(9):1006-1021.
28. Schwartz BS, Stewart WF, Bolla KI, Simon PD, Bandeen-Roche K, Gordon PB, Links JM, Todd AC. 2000. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology 55(8):1144-1150.
29. Schwartz BS, Lee BK, Lee GS, Stewart WF, Lee SS, Hwang KY, Ahn KD, Kim YB, Bolla KI, Simon D, Parsons PJ, Todd AC. 2001. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol 153(5):453-464.
30. Schwartz BS, Glass TA, Bolla KI, Stewart WF, Glass G, Rasmussen M, Bressler J, Shi W, Bandeen-Roche K. 2004. Disparities in cognitive functioning by race/ethnicity in the Baltimore memory study. Environ Health Perspect 112(3):314-320.
31. Schwartz BS, Lee BK, Bandeen-Roche K, Stewart W, Bolla K, Links J, V W, Todd A. 2005. Occupational lead exposure and longitudinal decline in neurobehavioral test scores. Epidemiology 16(1):106-113.
32. Sharifi AM, Baniasadi S, Jorjani M, Rahimi F, Bakhshayesh M. 2002. Investigation of acute lead poisoning on apoptosis in rat hippocampus in vivo. Neurosci Lett 329(1):45-48.
33. Shih RA, Glass TA, Bandeen-Roche K, Carlson MC, Bolla KI, Todd AC, Schwartz BS. 2006. Environmental lead exposure and cognitive function in community-dwelling older adults. Neurology 67:1556-1562.
34. Somervaille LJ, Chettle DR, Scott MC, Tennant DR, McKiernan MJ, Skilbeck A, Trethowan WN. 1988. In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects. Br J Ind Med 45(3):174-181.
35. Stewart WF, Schwartz BS, Simon D, Bolla KI, Todd AC, Links J. 1999. Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers. Neurology 52(8):1610-1617.
36. Stewart WF, Schwartz BS, Davatzikos C, Shen D, Liu D, Wu X, Todd AC, Shi W, Bassett S, Youssem D. 2006. Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology 66(10):1476-1484.
37. Todd AC, McNeill FE. 1993. In vivo measurements of lead in bone using a 109Cd 'spot' source. Basic Life Sci 60:299-302.
38. Todd AC, McNeill FE, Fowler BA. 1992. In vivo X-ray fluorescence of lead in bone. Environ Res 59(2):326-335.
39. Virgolini MB, Volosin M, Fulginiti AS, Cancela LM. 2004. Amphetamine and stress responses in developmentally lead-exposed rats. Neurotoxicol Teratol 26(2):291-303.
40. Virgolini MB, Chen K, Weston DD, Bauter MR, Cory-Slechta DA. 2005. Interactions of chronic lead exposure and intermittent stress: Consequences for brain catecholamine systems and associated behaviors and HPA axis function. Toxicol Sci 87(2):469-482.
41. Virgolini MB, Bauter MR, Weston DD, Cory-Slechta DA. 2006. Permanent alterations in stress responsivity in female offspring subjected to combined maternal lead exposure and/or stress. Neurotoxicology 27(1):11-21.
42. Walsh TJ, McLamb RL, Bondy SC, Tilson HA, Chang LW. 1986. Triethyl and trimethyl lead: Effects on behavior, CNS morphology and concentrations of lead in blood and brain of rat. Neurotoxicology 7(3):21-33.
43. Weisskopf MG, Wright RO, Schwartz J, Spiro A 3rd, Sparrow D, Aro A, Hu H. 2004. Cumulative lead exposure and prospective change in cognition among elderly men: The VA normative aging study. Am J Epidemiol 160(12):1184-1193.
44. Winker R, Barth A, Ponocny-Seliger E, Pilger A, Osterode W, Rudiger HW. 2005. No cognitive deficits in men formerly exposed to lead. Wien Klin Wochenschr 117(21-22):755-760.
45. Winker R, Ponocny-Seliger E, Rudiger HW, Barth A. 2006. Lead exposure levels and duration of exposure absence predict neurobehavioral performance. Int Arch Occup Environ Health 79(2):123-127.
46. Wright RO, Tsaih SW, Schwartz J, Spiro A 3rd, McDonald K, Weiss ST, Hu H. 2003. Lead exposure biomarkers and mini-mental status exam scores in older men. Epidemiology 14(6):713-718.